Advanced Search

Technical Analysis for TCBP - TC BioPharm (Holdings) plc

Grade Last Price % Change Price Change
D 0.953 -6.57% -0.07
TCBP closed down 6.57 percent on Monday, May 16, 2022, on 6 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical TCBP trend table...
Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -6.57%
Gapped Up Strength -6.57%
Oversold Stochastic Weakness -6.57%
Stochastic Reached Oversold Weakness 0.32%
Strong but Oversold Other 0.32%
Wide Bands Range Expansion 0.32%
Older End-of-Day Signals for TCBP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 8 hours ago
60 Minute Opening Range Breakdown about 10 hours ago
Lower Bollinger Band Support about 10 hours ago
Down 5% about 11 hours ago
Down 3% about 11 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates would target antigens expressed on various solid tumor types. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Solid Tumors Immune System Immunotherapy Cancer Treatment Cancer Immunotherapy Cell Biology Acute Myeloid Leukemia Cell Therapy Treatment Of Acute Myeloid Leukemia Immunotherapy Products T Cells

Is TCBP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
May 3 TC BioPharm Invited to Present at LD Micro Conference
Apr 26 TC BioPharm to Participate in Upcoming Conferences
Apr 21 TC BioPharm Donates to Leukemia and Lymphoma Society in Sponsorship of World AML Day
Apr 6 TC BioPharm Secures CryoTC Trademark For Cell Freezing Process
Apr 6 TC BioPharm Receives CryoTC® Trademark for Proprietary Cell Freezing Process
Mar 29 TC BioPharm Announces Initiation of Equity Analyst Coverage by EF Hutton with a "Buy" Recommendation
Mar 23 TC Biopharm receives approval from UK health agency to begin leukemia therapy trials
Mar 23 TC BioPharm Receives MHRA and Research Ethics Committee Approvals to Initiate Phase 2B/3 Clinical Trials for the Treatment of Acute Myeloid Leukemia
Mar 17 TC Biopharm stock up 31% as FDA grants orphan drug tag to leukemia treatment
Mar 17 TC BioPharm Announces FDA Orphan Drug Status Granted for OmnImmune®
See more TCBP news...

Indicators

Indicator Value
52 Week High 3.5
52 Week Low 0.88
Average Volume 1,442,986
200-Day Moving Average 0.00
50-Day Moving Average 1.26
20-Day Moving Average 1.24
10-Day Moving Average 1.22
Average True Range 0.20
RSI 38.27
ADX 20.28
+DI 16.54
-DI 19.77
Chandelier Exit (Long, 3 ATRs) 0.97
Chandelier Exit (Short, 3 ATRs) 1.53
Upper Bollinger Bands 1.56
Lower Bollinger Band 0.91
Percent B (%b) 0.07
BandWidth 52.68
MACD Line -0.07
MACD Signal Line -0.03
MACD Histogram -0.0431
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.12
Resistance 3 (R3) 1.14 1.10 1.09
Resistance 2 (R2) 1.10 1.06 1.09 1.08
Resistance 1 (R1) 1.03 1.03 1.01 1.01 1.07
Pivot Point 0.99 0.99 0.98 0.98 0.99
Support 1 (S1) 0.92 0.95 0.90 0.90 0.83
Support 2 (S2) 0.88 0.92 0.87 0.82
Support 3 (S3) 0.81 0.88 0.82
Support 4 (S4) 0.79